UBC Department of Medicine Researchers Awarded over $4.4M in CIHR Fall 2021 Project Grant Competition
The Project Grant program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.
It supports projects or programs of research proposed and conducted by individual researchers or groups of researchers in all areas of health. The Project Grants: Fall 2021 competition has approved 417 research grants for a total investment of approximately $325M.
UBC Department of Medicine researchers have been awarded $4.4M for 9 projects at the university and its affiliated health authority research centres through the Project Grant: Fall 2021 Competition from the Canadian Institutes for Health Research (CIHR).
FULL PROJECT GRANTS
Principal Investigator(s): Sean Barbour and Mark Canney (Division of Nephrology), and Chris Fordyce (Division of Cardiology) – $236,385 (3 years)
Improving cardiovascular risk prediction in patients with glomerular disease
Principal Investigator: Gordon Francis (Division of Endocrinology) – $674,605 (5 years)
The importance of smooth muscle foam cells in atherosclerosis development and treatment
Principal Investigator: Kevin Hay (Division of Hematology) – $1,667,700 (4 years)
A Phase I first-in-human trial of CLIC-2201, a VHH-CD22 CAR-T cell product for the treatment of relapsed/refractory CD22 positive B-cell non-Hodgkin lymphoma
Principal Investigator(s): Mypinder Sekhon (Division of Critical Care Medicine) and Ryan Hoiland (Department of Anesthesiology, Pharmacology, & Therapeutics) – $321,300 (4 years)
Impact of blood transfusion on cerebral blood flow regulation in experimental and pathological brain hypoxia in humans.
Principal Investigator: John Staples (Division of General Internal Medicine) – $336,600 (4 years)
Schizophrenia treatment adherence and driver responsibility for motor vehicle crash
Principal Investigator(s): Lianping Ti and Seonaid Nolan (Division of Social Medicine) – $447,525 (3 years)
Opioid tapering: Identifying optimal strategies to reduce adverse events among adults on long-term opioid therapy
Principal Investigator: Teresa Tsang (Division of Cardiology) – $581,401 (3 years)
Using Artificial Intelligence, Big Data and Imaging to Improve Stroke Risk Assessment and Management
PRIORITY ANNOUNCEMENT GRANTS
Ted Steiner (Division of Infectious Diseases) – $100,000
Exploring the potential of type-1 regulatory T cells in treatment and recovery from intestinal inflammation in inflammatory bowel disease
Janice Leung (Division of Respiratory Medicine) – $80,000
Imaging, Molecular, and Clinical Biomarkers of Accelerated Lung Aging in People Living with Human Immunodeficiency Virus (AGE-HIV)